Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2024. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 26.0B USD
- Positions
- 82
- Share of the ten largest
- 41.4%
The ten largest positions Q2 2024
- Amazon 6.9%▲ +34.6%
- Adobe Inc. 4.9%▲ +304.7%
- Philip Morris International 4.2%▼ −16.2%
- Microsoft 3.9%▲ +43.5%
- Api Group Corp 3.9%▼ −6.7%
- U.S. Bancorp 3.9%▲ +12.3%
- Apple Inc. 3.7%▲ +18.6%
- Workday, Inc. 3.4%▼ −25.1%
- Las Vegas Sands 3.4%▲ +16.9%
- Progressive Corporation 3.2%▲ +32.1%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2024
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| AMZN Amazon | 6.9% | 9,293,613 | 1.8B USD | +34.6% increased | Q2 2015 37 quarters |
| Bridgebio Pharma Inc | 2.4% | 25,120,991 | 636.3M USD | unchanged | Q2 2019 21 quarters |
| Adaptive Biotechnologies Cor | 0.4% | 29,993,708 | 108.6M USD | unchanged | Q2 2019 21 quarters |
| FTV Fortive | 2.9% | 10,039,510 | 743.9M USD | +5.7% increased | Q3 2019 20 quarters |
| Api Group Corp | 3.9% | 27,032,516 | 1.0B USD | −6.7% reduced | Q2 2020 17 quarters |
| Royalty Pharma PLC | 1.2% | 11,970,058 | 315.7M USD | +4.2% increased | Q2 2020 17 quarters |
| Acadia Healthcare Company In | 0.8% | 3,236,785 | 218.6M USD | +26.2% increased | Q4 2020 15 quarters |
| META Meta Platforms | 0.5% | 266,259 | 134.3M USD | −63.6% reduced | Q4 2020 15 quarters |
| 4D Molecular Therapeutics In | 0.2% | 2,934,914 | 61.6M USD | unchanged | Q4 2020 15 quarters |
| AMP Ameriprise Financial | 1.5% | 909,020 | 388.3M USD | −44.1% reduced | Q1 2021 14 quarters |
| Pharvaris N V | 0.3% | 3,653,310 | 68.7M USD | unchanged | Q1 2021 14 quarters |
| Zai Lab Ltd | 0.1% | 2,037,374 | 35.3M USD | −0.5% reduced | Q1 2021 14 quarters |
| Edgewise Therapeutics Inc | 0.1% | 1,481,146 | 26.7M USD | −55.6% reduced | Q1 2021 14 quarters |
| Day One Biopharmaceuticals I | 0.1% | 2,558,563 | 35.3M USD | unchanged | Q2 2021 13 quarters |
| Hdfc Bank Ltd | 2.2% | 8,756,864 | 563.3M USD | +47.7% increased | Q3 2021 12 quarters |
| Ginkgo Bioworks Holdings Inc | 0.2% | 143,085,126 | 47.8M USD | unchanged | Q3 2021 12 quarters |
| Rallybio Corp | < 0.1% | 4,194,777 | 5.6M USD | unchanged | Q3 2021 12 quarters |
| Roivant Sciences Ltd | 2.8% | 69,155,846 | 731.0M USD | −0.3% reduced | Q4 2021 11 quarters |
| Biomarin Pharmaceutical Inc | 2.2% | 7,063,564 | 581.5M USD | +10.1% increased | Q4 2021 11 quarters |
| PGR Progressive Corporation | 3.2% | 4,006,859 | 832.3M USD | +32.1% increased | Q1 2022 10 quarters |
| MCK McKesson Corporation | 0.3% | 142,169 | 83.0M USD | −75.9% reduced | Q2 2022 9 quarters |
| Pepgen Inc | < 0.1% | 1,482,434 | 23.7M USD | unchanged | Q2 2022 9 quarters |
| UNH UnitedHealth Group | 0.9% | 441,795 | 225.0M USD | −67.5% reduced | Q3 2022 8 quarters |
| Trevi Therapeutics Inc | < 0.1% | 4,400,000 | 13.1M USD | unchanged | Q3 2022 8 quarters |
| CSX CSX Corporation | 0.6% | 4,738,544 | 158.5M USD | +19.7% increased | Q4 2022 7 quarters |
| Newamsterdam Pharma Company | 0.6% | 8,024,565 | 154.2M USD | unchanged | Q4 2022 7 quarters |
| WDAY Workday, Inc. | 3.4% | 3,959,965 | 885.3M USD | −25.1% reduced | Q1 2023 6 quarters |
| Viking Therapeutics Inc | 0.3% | 1,354,450 | 71.8M USD | +23.7% increased | Q1 2023 6 quarters |
| PM Philip Morris International | 4.2% | 10,912,378 | 1.1B USD | −16.2% reduced | Q2 2023 5 quarters |
| CBRE CBRE Group | 1.2% | 3,620,575 | 322.6M USD | −20.8% reduced | Q2 2023 5 quarters |
| Epam Sys Inc | 0.5% | 756,261 | 142.3M USD | +30.5% increased | Q2 2023 5 quarters |
| FIVE9 Inc | 0.3% | 1,734,414 | 76.5M USD | −49.8% reduced | Q2 2023 5 quarters |
| FCX Freeport-McMoRan | 1.0% | 5,229,917 | 254.2M USD | −45.0% reduced | Q3 2023 4 quarters |
| ISRG Intuitive Surgical | 0.6% | 337,893 | 150.3M USD | −56.2% reduced | Q3 2023 4 quarters |
| USB U.S. Bancorp | 3.9% | 25,404,913 | 1.0B USD | +12.3% increased | Q4 2023 3 quarters |
| TMUS T-Mobile US | 1.7% | 2,492,802 | 439.2M USD | −43.1% reduced | Q4 2023 3 quarters |
| TEAM Atlassian | 1.0% | 1,465,977 | 259.3M USD | −16.2% reduced | Q4 2023 3 quarters |
| HCA HCA Healthcare | 0.8% | 654,167 | 210.2M USD | +23.6% increased | Q4 2023 3 quarters |
| Regal Rexnord Corporation | 0.6% | 1,123,163 | 151.9M USD | +24.7% increased | Q4 2023 3 quarters |
| LLY Lilly (Eli) | 0.5% | 144,175 | 130.5M USD | +7.1% increased | Q4 2023 3 quarters |
| Procore Technologies Inc | 0.4% | 1,374,580 | 91.1M USD | +38.7% increased | Q4 2023 3 quarters |
| KKR KKR & Co. | 0.2% | 545,092 | 57.4M USD | −49.1% reduced | Q4 2023 3 quarters |
| ADBE Adobe Inc. | 4.9% | 2,276,627 | 1.3B USD | +304.7% increased | Q1 2024 2 quarters |
| MSFT Microsoft | 3.9% | 2,292,331 | 1.0B USD | +43.5% increased | Q1 2024 2 quarters |
| AAPL Apple Inc. | 3.7% | 4,590,693 | 966.9M USD | +18.6% increased | Q1 2024 2 quarters |
| LVS Las Vegas Sands | 3.4% | 19,785,682 | 875.5M USD | +16.9% increased | Q1 2024 2 quarters |
| DLTR Dollar Tree | 2.8% | 6,808,797 | 727.0M USD | +164.7% increased | Q1 2024 2 quarters |
| CPT Camden Property Trust | 1.4% | 3,259,567 | 355.7M USD | +216.4% increased | Q1 2024 2 quarters |
| Ferguson PLC New | 1.2% | 1,673,699 | 324.1M USD | +91.2% increased | Q1 2024 2 quarters |
| Equitable HLDGS Inc | 0.9% | 5,859,547 | 239.4M USD | +184.8% increased | Q1 2024 2 quarters |
| Integer HLDGS Corp | 0.5% | 1,111,779 | 128.7M USD | +159.5% increased | Q1 2024 2 quarters |
| Standard Biotools Inc | 0.4% | 58,651,170 | 103.8M USD | unchanged | Q1 2024 2 quarters |
| OSCR Oscar Health | 0.4% | 5,928,038 | 93.8M USD | +25.3% increased | Q1 2024 2 quarters |
| Immunovant Inc | 0.2% | 2,320,902 | 61.3M USD | +28.3% increased | Q1 2024 2 quarters |
| VRT Vertiv | 0.2% | 689,687 | 59.7M USD | −32.3% reduced | Q1 2024 2 quarters |
| Longboard Pharmaceuticals In | 0.2% | 1,658,962 | 44.8M USD | +69.1% increased | Q1 2024 2 quarters |
| Oric Pharmaceuticals Inc | 0.1% | 4,000,000 | 28.3M USD | unchanged | Q1 2024 2 quarters |
| NFLX Netflix | 2.4% | 932,867 | 629.6M USD | new | Q2 2024 1 quarter |
| JPM JPMorgan Chase | 2.3% | 3,009,822 | 608.8M USD | new | Q2 2024 1 quarter |
| DASH DoorDash | 2.3% | 5,535,921 | 602.2M USD | new | Q2 2024 1 quarter |
| Mcdonalds Corp | 1.8% | 1,876,019 | 478.1M USD | new | Q2 2024 1 quarter |
| AVGO Broadcom | 1.8% | 293,097 | 470.6M USD | new | Q2 2024 1 quarter |
| GEV GE Vernova | 1.6% | 2,428,614 | 416.5M USD | new | Q2 2024 1 quarter |
| F Ford Motor Company | 0.9% | 18,789,638 | 235.6M USD | new | Q2 2024 1 quarter |
| INTU Intuit | 0.8% | 335,994 | 220.8M USD | new | Q2 2024 1 quarter |
| DDOG Datadog | 0.7% | 1,376,071 | 178.5M USD | new | Q2 2024 1 quarter |
| NVDA Nvidia | 0.7% | 1,384,547 | 171.0M USD | new | Q2 2024 1 quarter |
| MMM 3M | 0.6% | 1,644,145 | 168.0M USD | new | Q2 2024 1 quarter |
| UBS Group AG | 0.6% | 5,186,506 | 152.7M USD | new | Q2 2024 1 quarter |
| Spotify Technology S A | 0.6% | 474,981 | 149.0M USD | new | Q2 2024 1 quarter |
| CHTR Charter Communications | 0.5% | 438,601 | 131.1M USD | new | Q2 2024 1 quarter |
| SHW Sherwin-Williams | 0.5% | 407,786 | 121.7M USD | new | Q2 2024 1 quarter |
| APO Apollo Global Management | 0.4% | 971,224 | 114.7M USD | new | Q2 2024 1 quarter |
| CRM Salesforce | 0.4% | 405,135 | 104.2M USD | new | Q2 2024 1 quarter |
| ALL Allstate | 0.3% | 545,182 | 87.0M USD | new | Q2 2024 1 quarter |
| NRG NRG Energy | 0.3% | 943,457 | 73.5M USD | new | Q2 2024 1 quarter |
| CVNA Carvana | 0.3% | 553,621 | 71.3M USD | new | Q2 2024 1 quarter |
| Insmed Inc | 0.3% | 1,035,970 | 69.4M USD | new | Q2 2024 1 quarter |
| Lpl Finl HLDGS Inc | 0.1% | 130,000 | 36.3M USD | new | Q2 2024 1 quarter |
| Rubrik Inc. | 0.1% | 897,170 | 27.5M USD | new | Q2 2024 1 quarter |
| Inhibrx Biosciences Inc | < 0.1% | 1,787,705 | 25.3M USD | new | Q2 2024 1 quarter |
| Sanofi | < 0.1% | 326,290 | 15.8M USD | new | Q2 2024 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Technology 20.3%
- Consumer Discretionary 13.8%
- Financials 11.9%
- Consumer Staples 7.0%
- Industrials 5.9%
- Communication Services 5.1%
- Health Care 3.1%
- Real Estate 2.6%
- Materials 1.4%
- Utilities 0.3%
- not in our coverage 28.5%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors